Oversano (Ketorolac Trometamol)

Ketorolac Trometamol, the active ingredient in Oversano, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as a tablet for oral use. It is employed for short‑term management of moderate to severe pain, typically after surgical procedures, in adult patients. GNH USA supplies Oversano as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oversano as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ketorolac Trometamol is an NSAID that provides analgesic and anti‑inflammatory effects for several acute pain conditions.

- Post‑operative pain: helps achieve effective pain relief after surgery. - Renal colic: reduces pain associated with kidney stones. - Musculoskeletal injury: alleviates pain from sprains, strains and contusions. - Acute migraine (off‑label): may lessen headache intensity when other treatments fail. - Dental pain: provides short‑term relief following dental procedures.

Ketorolac Trometamol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Elevated blood pressure. - Renal function changes: transient increase in serum creatinine. - Injection site irritation (if administered parenterally).

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Severe hypersensitivity reactions including anaphylaxis. - Thrombotic events such as myocardial infarction or stroke. - Acute kidney injury. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatotoxicity.

Ketorolac Trometamol should be used with caution and under professional supervision.

- Assess renal function: avoid use in patients with severe renal impairment. - Monitor gastrointestinal risk: use gastro‑protective agents in high‑risk individuals. - Evaluate cardiovascular status: avoid in patients with recent myocardial infarction. - Limit duration: restrict use to the shortest possible period, generally not exceeding five days. - Review concomitant NSAID or anticoagulant therapy: increase bleeding risk. - Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Ketorolac Trometamol can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): increased bleeding tendency.

Moderate Interactions (Monitor Closely): - ACE inhibitors, ARBs: may reduce renal perfusion and function. - Diuretics: potential for reduced kidney function. - Lithium: NSAIDs can raise lithium serum levels. - Methotrexate: decreased renal clearance may increase toxicity. - Corticactives (e.g., prednisone): heightened risk of ulceration.